Transactions
3
Insider / AbbVie Inc.
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER at AbbVie Inc. · ABBV
Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER at AbbVie Inc., has disclosed 3 transactions in ABBV since August 18, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $10.8M at the reported prices. The latest was filed August 18, 2026, 4 days after the trade.
Open-market buys
0
Sales
1
Avg. disclosure lag
4.0d
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source |
|---|---|---|---|---|---|---|---|---|---|
| ABBV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 32,710 | — | — | derivative | Form 4 ↗ |
| ABBV | Sell S | August 14, 2026 | August 18, 2026 | 4d | 32,710 | $250 | $8.2M | Form 4 ↗ | |
| ABBV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 32,710 | $79 | $2.6M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 18, 2026 | Form 4 | 0001762951-26-000006 | 3 | published | EDGAR ↗ |
Sources and method
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.